Hyponatraemia in heart failure: a call for redefinition
نویسندگان
چکیده
منابع مشابه
Hyponatraemia as a marker for high renin heart failure.
The factors that might activate the renin-angiotensin system in treated heart failure were explored. Serum Na+ correlated inversely with plasma renin activity. The degree of congestive heart failure measured by right atrial pressure, pulmonary capillary wedge pressure, cardiac index, and systemic vascular resistance did not correlate with plasma renin activity. Similarly, renal function as meas...
متن کاملHyponatraemia in congestive heart failure during treatment with captopril.
SHORT REPORTS Hyponatraemia in congestive heart failure during treatment with captopril The oral converting-enzyme inhibitor captopril shows promise in the treatment of cardiac failure. We used the drug in five patients with congestive heart failure that had proved unresponsive to conventional treatment and observed a clear-cut fall in plasma sodium concentration. Methods and results We studied...
متن کاملAdvanced heart failure: a call to action.
Despite improvements in medical therapy for heart failure, more than 250,000 people die in the United States as a result of heart failure each year. There are multiple risk factors and models that have been created to identify these people, yet there has not been a significant impact on outcomes or change in the therapies for these patients. The authors review the available therapies for patien...
متن کاملDefining diastolic heart failure: a call for standardized diagnostic criteria.
Congestive heart failure (CHF) is a major public health problem in developed countries.1–3 It is a significant burden to patients, healthcare providers, and society.2–4 Several hospital-based reports have documented that a high proportion of patients with CHF have normal left ventricular (LV) systolic function,5 and 4 different epidemiological investigations further confirmed that nearly half o...
متن کاملEmerging Drug Therapies for Heart Failure
Heart failure is associated with high morbidity and mortality and is proving to be an economic burden in developing countries. A number of therapeutic agents are presently employed in heart failure; but they are not sufficient to control symptoms of heart failure. Moreover, the prevalence of chronic heart failure is progressively increasing and thus there is a continuing need to develop effecti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal
سال: 2007
ISSN: 0195-668X,1522-9645
DOI: 10.1093/eurheartj/ehm046